Hyalgan 20mg Injection 2ml

Arthritis (135)Rx required

Key Information

Generic Name

Generic Name Hyaluronic Acid 20 mg

Manufacturer

Lupin Ltd

Country of Origin

India

Detailed Information

Introduction

INTRODUCTIONHYALGAN 20MG contains Sodium hyaluronate which belongs to the group of medicine called viscoelastic supplements. It is used to manage pain in knee osteoarthritis among patients who have failed to respond adequately to simple analgesics and conservative non-pharmacologic therapy. Sodium hyaluronate is available as a salt form of hyaluronic acid. Hyaluronic acid is a natural polysaccharide present in very high amounts in the synovial fluid (fluid surrounding the joint) and acts as a lubricant and shock absorber in between joints. People with knee osteoarthritis suffer a very low concentration of hyaluronic acid in their synovial fluid. Intra-articular administration of HYALGAN 20MG supplements hyaluronic acid to the synovial fluid and lubricates and cushions the joint. It also provides relief from joint friction and pain. It helps in absorption of shock created from normal physical activity like walking, running, jumping etc. This medicine should only be given as an intra-articular injection (in between joints). People taking this injection, or any other visco-supplementation should be advised to avoid any prolonged (for more than an hour) or strenuous activities (like lifting heavy weights, running, jumping) within 48 hours following intra-articular injection. Before administration, remove any joint effusion if present. The most common

Uses

OF HYALGAN 20MG Manages osteoarthritis of the knee

How It Works

In people with knee osteoarthritis, intra-articular administration of HYALGAN 20MG supplements the required amount of hyaluronic acid directly into the synovial fluid. This leads to enhanced joint lubrication and absorption of shock created from normal physical activity like walking, running, cycling or jumping. As a result, friction in between joint and pain are relieved.

Directions for Use

This medicine will be given to you only by an orthopedic surgeon in between the joints (intra-articular injection). Your doctor will decide the correct dose and duration for you depending upon your age, body weight and health condition. Strict aseptic condition must be followed during the process. Before administration, remove any joint effusion if present. Do not inject this medicine intravascularly because it may lead to unwanted systemic

Side Effects

HYALGAN 20MGCOMMON injection site reactions (such as joint pain, swelling, redness and warmth) nasopharyngitis upper respiratory tract infections, fever pain in extremity cystitis nausea, diarrhea, dyspepsia paresthesia (numbness of arms, legs or feet) musculoskeletal pain plantar fasciitis (pain of heels of feet)

Warnings & Precautions

& PRECAUTIONSPREGNANCYHYALGAN 20MG is not recommended for use in pregnant women due to lack of safety data. Consult your doctor for advice. BREASTFEEDINGHYALGAN 20MG is not recommended for use in breastfeeding women due to lack of safety data. Consult your doctor for advice. LIVERHYALGAN 20MG should be taken with caution in patients with liver disease. Consult your doctor for advice. ALLERGYDo not take this medicine if you are allergic to sodium hyaluronate. OTHERSDo not take this medicine, if you have: any infection or inflammation at the joint cavity or any other skin disease at the site of injection (knee)

Drug Interactions

STalk to your doctor, if you are taking, quaternary ammonium salts or chlorhexidine (used as topical disinfectants) SYNOPSIS Drug : Sodium hyaluronate Pharmacological Category : Viscoelastic substance, Ophthalmic lubricants, Dermatological agent, Pharmaceutical aid Therapeutic Indication : Knee osteoarthritis Dosage Forms : Tablet, Capsule, Cream, Gel, Eye drops, Ophthalmic injectable solution, Injection MORE INFORMATIONStore in a refrigerator at 2-8°C and keep out of reach of children.

Article Information

I(

Written By

ity (HPRA). [Revised on December 2009] [Accessed 18th December 2020] https://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_PA0814-001-001_05042016103037.pdf 8. Fidia Farmaceutici S.p.A. Hyalgan.com. [Revised on May 2014] [Accessed 18th December 2020] https://hyalgan.com/wp-content/uploads/2016/02/hyalgan_pi.pdf 9. Cipla. Ltd. HYRUAN OneTM Injection (Cross-linked Hyaluronic Acid 20mg/mL). Ciplamed.com [Revised on January 2019] [Accessed 18th December 2020] https://ciplamed.com/content/hyruan-onetm-injection 10. Genzyme Biosurgery, A division of Genzyme Corporation. SYNVISC ONE® HYLAN G-F 20. [Revised on September 2014] [Accessed 18th December 2020] https://products.sanofi.us/synviscone/synviscone.html 11. Central Drugs Standard Control Organisation (CDSCO). Sodium Hyaluronate Injection 8mg/vial (6ml Pre-filled syringe for Intra Articular use only). [Revised on April 2012] [Accessed 18th December 2020] https://cdscoonline.gov.in/CDSCO/Drugs USEFUL DIAGNOSTIC TESTS Blood calcium levels Rheumatoid Factor IgG Antibody Rheumatoid Factor IgM Antibody

Medical Content Writer

Tags

#arthritis (135)#generic name hyaluronic acid 20 mg